This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Feb 1;20(1 suppl 1):220-222.

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs

A Zeevi¹, R Duquesnoy, G Eiras, H Rabinowich, S Todo, L Makowka, T E Starzl

Affiliations

PMID: 21307965
PMCID: PMC3034377

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs

A Zeevi et al. Transplant Proc. 1988.

. 1988 Feb 1;20(1 suppl 1):220-222.

Authors

A Zeevi¹, R Duquesnoy, G Eiras, H Rabinowich, S Todo, L Makowka, T E Starzl

Affiliation

¹ Divisions of Pathology and Surgery, University of Pittsburgh, School of Medicine.

PMID: 21307965
PMCID: PMC3034377

No abstract available

PubMed Disclaimer

Figures

Fig 1 — Fig 1
Effect of low doses of FK and CsA on MLR. Inhibitions of MLR in the presence of different concentrations of FK (0.05 and 0.025 ng/mL) were 2% and 0%, respectively. (■), CsA + FK 0.05 ng/ml; (), CsA + FK 0.025 ng/ml; (□), CsA.

formula image — Fig 1
Effect of low doses of FK and CsA on MLR. Inhibitions of MLR in the presence of different concentrations of FK (0.05 and 0.025 ng/mL) were 2% and 0%, respectively. (■), CsA + FK 0.05 ng/ml; (), CsA + FK 0.025 ng/ml; (□), CsA.

Fig 2 — Fig 2
Effect of low doses of FK and Aza on MLR. Inhibitions of MLR in the presence of different concentrations of FK (0.05 and 0.01 ng/mL) were 7% and 4%, respectively. (■), Aza + FK 0.05 ng/ml; (), Aza + FK 0.01 ng/ml; (□), Aza.

formula image — Fig 2
Effect of low doses of FK and Aza on MLR. Inhibitions of MLR in the presence of different concentrations of FK (0.05 and 0.01 ng/mL) were 7% and 4%, respectively. (■), Aza + FK 0.05 ng/ml; (), Aza + FK 0.01 ng/ml; (□), Aza.

See this image and copyright information in PMC

Similar articles

Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
Johansson A, Möller E. Johansson A, et al. Transplantation. 1990 Dec;50(6):1001-7. doi: 10.1097/00007890-199012000-00021. Transplantation. 1990. PMID: 1701570
In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates.
Lee Y, Lee KT, Lee SJ, Beom JY, Hwangbo A, Jung JA, Song MC, Yoo YJ, Kang SH, Averette AF, Heitman J, Yoon YJ, Cheong E, Bahn YS. Lee Y, et al. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01627-18. doi: 10.1128/AAC.01627-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30181374 Free PMC article.
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada S, Suzuki G, Kawase Y, Takaku F. Sawada S, et al. J Immunol. 1987 Sep 15;139(6):1797-803. J Immunol. 1987. PMID: 2442255
[Immunosuppressive activity of a microbial product].
Hatanaka H, Shimomura K. Hatanaka H, et al. Nihon Yakurigaku Zasshi. 1997 Oct;110 Suppl 1:69P-74P. doi: 10.1254/fpj.110.supplement_69. Nihon Yakurigaku Zasshi. 1997. PMID: 9503409 Review. Japanese.
Development of Non-Immunosuppressive FK506 Derivatives as Antifungal and Neurotrophic Agents.
Jung JA, Yoon YJ. Jung JA, et al. J Microbiol Biotechnol. 2020 Jan 28;30(1):1-10. doi: 10.4014/jmb.1911.11008. J Microbiol Biotechnol. 2020. PMID: 31752059 Free PMC article. Review.

See all similar articles

Cited by

Pharmacokinetics of FK 506: preclinical and clinical studies.
Venkataramanan R, Jain A, Cadoff E, Warty V, Iwasaki K, Nagase K, Krajack A, Imventarza O, Todo S, Fung JJ, et al. Venkataramanan R, et al. Transplant Proc. 1990 Feb;22(1):52-6. Transplant Proc. 1990. PMID: 1689899 Free PMC article. No abstract available.
New approaches in the use of cyclosporine: with particular reference to the liver.
Starzl TE. Starzl TE. Transplant Proc. 1988 Jun;20(3 Suppl 3):356-60. Transplant Proc. 1988. PMID: 3291267 Free PMC article.
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.
Zeevi A, Eiras G, Kaufman C, Alessiani M, Demetris AJ, Abu-Elmagd K, Jain A, Warty V, Venkataramanan R, Burckart G, et al. Zeevi A, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1406-8. Transplant Proc. 1991. PMID: 1703341 Free PMC article. No abstract available.
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Tanabe M, Todo S, Murase N, Irish W, Miyazawa H, Fujisaki S, Starzl TE. Tanabe M, et al. Transplant Proc. 1995 Feb;27(1):364-5. Transplant Proc. 1995. PMID: 7533411 Free PMC article. No abstract available.
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.
Zeevi A, Eiras G, Bach FH, Fung JJ, Todo S, Starzl T, Duquesnoy RJ. Zeevi A, et al. Transplant Proc. 1990 Feb;22(1):106-9. Transplant Proc. 1990. PMID: 1689884 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Ochiai T, Nakajima K, Kagala M, et al. Transplant Proc. 1987;19:1284. - PubMed
1. Zeevi A, Duquesnoy RJ, Eiras G, et al. Surg Res Commun. 1987;1:315. - PMC - PubMed
1. Zeevi A, Duquesnoy RJ, Eiras G, et al. Transplant Proc. 1987;19 suppl 6:40. - PMC - PubMed
1. Lee P, Murase N, Todo S, et al. Surg Res Commun. 1987;1:325. - PMC - PubMed
1. Todo S, Makowka L, Starzl T. Surg Res Commun. 1987;1:330. - PMC - PubMed

Grants and funding

R01 DK029961/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central